UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New IBD genetics: common pathways with other diseases

Gut, 2011-12, Vol.60 (12), p.1739-1753

2011

Volltextzugriff (PDF)

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

Gut, 2006-06, Vol.55 (6), p.749-753

2006

Volltextzugriff (PDF)

Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications

Mucosal immunology, 2016-05, Vol.9 (3), p.567-582

2016

Volltextzugriff (PDF)

MicroRNAs: new players in IBD

Gut, 2015-03, Vol.64 (3), p.504-513

2015

Volltextzugriff (PDF)

Guidelines for the management of inflammatory bowel disease in adults

Gut, 2011-05, Vol.60 (5), p.571-607

2011

Volltextzugriff (PDF)

Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers

Gut, 2011-01, Vol.60 (1), p.3-9

2011

Volltextzugriff (PDF)

Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease

Journal of Crohn's and colitis, 2021-05, Vol.15 (5), p.699-708

2021

Volltextzugriff (PDF)

Editorial: the influence of genetic factors in mediating the effects of tobacco smoke in IBD

Alimentary pharmacology & therapeutics, 2018-01, Vol.47 (2), p.306-307

2018

Volltextzugriff (PDF)

MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation

Mucosal immunology, 2018-01, Vol.11 (1), p.120-130

2018

Volltextzugriff (PDF)

The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5‐year UK inception cohort

Alimentary pharmacology & therapeutics, 2006-07, Vol.24 (2), p.319-330

2006

Volltextzugriff (PDF)

Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis

The American journal of gastroenterology, 2009-03, Vol.104 (3), p.673-678

2009

Volltextzugriff (PDF)

Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character)

Scandinavian journal of gastroenterology, 2020-10, Vol.55 (10), p.1146-1156

2020

Volltextzugriff (PDF)

Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second‐line medical therapy or surgery

Alimentary pharmacology & therapeutics, 2004-05, Vol.19 (10), p.1079-1087

2004

Volltextzugriff (PDF)

Systematic review: the use of thiopurines or anti‐TNF in post‐operative Crohn's disease maintenance – progress and prospects

Alimentary pharmacology & therapeutics, 2014-06, Vol.39 (11), p.1253-1265

2014

Volltextzugriff (PDF)

Editorial: early corticosteroids in ulcerative colitis

Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (6), p.727-727

2014

Volltextzugriff (PDF)

Top-down in the Long Term in Crohn’s Disease

Journal of Crohn's and colitis, 2018-04, Vol.12 (5), p.513-514

2018

Volltextzugriff (PDF)

An analysis of factors influencing short‐term and sustained response to infliximab treatment for Crohn's disease

Alimentary pharmacology & therapeutics, 2003-06, Vol.17 (12), p.1451-1457

2003

Volltextzugriff (PDF)

Editorial: what can be done when infliximab stops working in ulcerative colitis?

Alimentary pharmacology & therapeutics, 2016-01, Vol.43 (1), p.164-164

2016

Volltextzugriff (PDF)

A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta‐analysis

Alimentary pharmacology & therapeutics, 2013-11, Vol.38 (10), p.1255-1266

2013

Volltextzugriff (PDF)

Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2020-12, Vol.14 (12), p.1724-1733

2020

Volltextzugriff (PDF)

Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis

Gut, 2008-10, Vol.57 (10), p.1398-1405

2008

Volltextzugriff (PDF)

Tolerability and safety of mercaptopurine in azathioprine‐intolerant patients with inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2008-02, Vol.27 (3), p.220-227

2008

Volltextzugriff (PDF)

P766 No difference in progression of disability 2 years after stopping infliximab or immunosuppressant vs. continuing combination therapy in patients with CD in sustained steroid-free remission: a subanalysis of SPARE

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1429-i1431

2024

Volltextzugriff (PDF)

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients

Alimentary pharmacology & therapeutics, 2014-12, Vol.40 (11-12), p.1313-1323

2014

Volltextzugriff (PDF)

Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis

Alimentary pharmacology & therapeutics, 2010-06, Vol.31 (12), p.1310-1321

2010

Volltextzugriff (PDF)

1 – 25 von 553

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(529)
Mit Volltextzugriff
(501)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(553)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(259)
Humans
(235)
Life Sciences & Biomedicine
(235)
Gastroenterology & Hepatology
(146)
Inflammatory Bowel Disease
(115)
Male
(110)
Female
(106)
Adult
(91)
Biological And Medical Sciences
(89)
Crohn's Disease
(82)
Medical Sciences
(82)
Crohn Disease - Genetics
(79)
Ulcerative Colitis
(71)
Gastroenterology. Liver. Pancreas. Abdomen
(64)
Other Diseases. Semiology
(63)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(60)
Colitis, Ulcerative - Genetics
(59)
Middle Aged
(57)
Inflammatory Bowel Diseases
(55)
Genetic Predisposition To Disease
(53)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

New IBD genetics: common pathways with other diseases

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications

MicroRNAs: new players in IBD

Guidelines for the management of inflammatory bowel disease in adults

Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers

Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease

Editorial: the influence of genetic factors in mediating the effects of tobacco smoke in IBD

MDR1 deficiency impairs mitochondrial homeostasis and promotes intestinal inflammation

The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5‐year UK inception cohort

Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis

Faecal microbiota signatures of IBD and their relation to diagnosis, disease phenotype, inflammation, treatment escalation and anti-TNF response in a European Multicentre Study (IBD-Character)

Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second‐line medical therapy or surgery

Systematic review: the use of thiopurines or anti‐TNF in post‐operative Crohn's disease maintenance – progress and prospects

Editorial: early corticosteroids in ulcerative colitis

Top-down in the Long Term in Crohn’s Disease

An analysis of factors influencing short‐term and sustained response to infliximab treatment for Crohn's disease

Editorial: what can be done when infliximab stops working in ulcerative colitis?

A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta‐analysis

Whole Blood Profiling of T-cell-Derived microRNA Allows the Development of Prognostic models in Inflammatory Bowel Disease

Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis

Tolerability and safety of mercaptopurine in azathioprine‐intolerant patients with inflammatory bowel disease

P766 No difference in progression of disability 2 years after stopping infliximab or immunosuppressant vs. continuing combination therapy in patients with CD in sustained steroid-free remission: a subanalysis of SPARE

Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients

Nationwide linkage analysis in Scotland implicates age as the critical overall determinant of mortality in ulcerative colitis

Suchergebnisse filtern